Allianz Asset Management GmbH
13F filer · CIK 0001535323Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$112.2BU.S. long equity reported on 13F
Positions1,42358 new · 57 closed
Net flow last quarter+$2.51BBuys minus sells
Top 10 positions weight20.8%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 20261,423 positions | |||||
| $5.42B | 4.83% | 0.12% | +24.9% | Q1 2015 | |
| $3.63B | 3.23% | 0.10% | +9.7% | Q1 2015 | |
| $2.95B | 2.63% | 0.11% | +5.4% | Q1 2015 | |
| $2.2B | 1.96% | 0.06% | +5.2% | Q4 2015 | |
| $2.18B | 1.94% | 0.09% | +20.9% | Q1 2015 | |
| $1.92B | 1.71% | Not reported | -31.5% | Q1 2025 | |
| $1.32B | 1.18% | Not reported | +3.2% | Q4 2015 | |
| $1.32B | 1.18% | Not reported | +4.6% | Q4 2015 | |
| $1.23B | 1.09% | Not reported | +17.0% | Q1 2015 | |
| $1.2B | 1.07% | 0.20% | -14.4% | Q1 2015 | |
| $1.11B | 0.99% | 0.07% | +6.8% | Q1 2016 | |
| $927M | 0.83% | 0.12% | +1.2% | Q1 2015 | |
| $854M | 0.76% | 0.22% | -6.0% | Q1 2015 | |
| $836M | 0.75% | 2.84% | +1.0% | Q1 2018 | |
| $748M | 0.67% | 0.37% | -0.1% | Q1 2015 | |
| $729M | 0.65% | 0.22% | -3.5% | Q1 2015 | |
| $724M | 0.65% | 0.42% | +10.0% | Q1 2015 | |
| $685M | 0.61% | 0.22% | -8.1% | Q1 2015 | |
| $674M | 0.60% | 0.11% | -2.2% | Q1 2015 | |
| $628M | 0.56% | 0.33% | +5.3% | Q1 2015 | |
| $562M | 0.50% | 0.13% | -8.1% | Q1 2015 | |
| $495M | 0.44% | 0.03% | -4.1% | Q1 2015 | |
| $482M | 0.43% | 0.41% | +20.3% | Q1 2015 | |
| PBPMBSPuramed Bioscience Inc. | $481M | 0.43% | 4.88% | +17.0% | Q1 2025 |
| $471M | 0.42% | 0.68% | +7.8% | Q1 2015 | |
| $460M | 0.41% | 0.12% | +4.3% | Q1 2015 | |
| $449M | 0.40% | 0.15% | -6.3% | Q1 2015 | |
| $446M | 0.40% | 0.13% | +2.8% | Q4 2020 | |
| $440M | 0.39% | 0.16% | -1.9% | Q1 2015 | |
| $440M | 0.39% | 0.05% | -5.5% | Q1 2015 | |
| $425M | 0.38% | 0.54% | +6.2% | Q1 2015 | |
| $420M | 0.37% | 0.24% | -0.9% | Q1 2015 | |
| $411M | 0.37% | 0.29% | -14.8% | Q1 2015 | |
| $399M | 0.36% | 0.53% | -8.1% | Q1 2015 | |
| $397M | 0.35% | 0.65% | +0.6% | Q1 2015 | |
| $394M | 0.35% | 0.00% | Not reported | Q1 2015 | |
| $381M | 0.34% | 0.49% | -10.3% | Q1 2015 | |
| $373M | 0.33% | 0.23% | -7.8% | Q1 2015 | |
| $368M | 0.33% | 0.09% | +12.4% | Q1 2015 | |
| $365M | 0.33% | 0.83% | +0.8% | Q1 2015 | |
| $362M | 0.32% | 0.64% | +9.6% | Q1 2015 | |
| $361M | 0.32% | 0.31% | +4.8% | Q1 2015 | |
| $354M | 0.32% | 0.40% | +62.1% | Q1 2015 | |
| $340M | 0.30% | 0.29% | +7.4% | Q1 2015 | |
| $340M | 0.30% | 1.21% | +0.5% | Q1 2015 | |
| $334M | 0.30% | 0.21% | -0.7% | Q1 2015 | |
| $331M | 0.30% | 0.16% | +2.9% | Q1 2015 | |
| $330M | 0.29% | 0.56% | +0.6% | Q1 2015 | |
| $328M | 0.29% | 1.71% | -0.1% | Q1 2015 | |
| $320M | 0.28% | 0.29% | +6.0% | Q1 2015 | |
| Q1 2026Reported May 11, 20261,421 positions | |||||
| $4.18B | 4.38% | 0.10% | +10.0% | Q1 2015 | |
| $3.96B | 4.15% | Not reported | -29.1% | Q1 2025 | |
| $3.23B | 3.39% | 0.09% | +8.4% | Q1 2015 | |
| $2.8B | 2.94% | 0.10% | +1.5% | Q1 2015 | |
| $2.04B | 2.14% | 0.06% | +7.3% | Q4 2015 | |
| $1.75B | 1.83% | 0.08% | -11.0% | Q1 2015 | |
| $1.39B | 1.46% | 0.24% | -5.5% | Q1 2015 | |
| $1.26B | 1.33% | Not reported | +333401.6% | Q4 2015 | |
| $1.26B | 1.32% | Not reported | +6.4% | Q4 2015 | |
| $1.05B | 1.10% | Not reported | -3.3% | Q1 2015 | |
| $1.01B | 1.06% | 0.07% | -6.8% | Q1 2016 | |
| $912M | 0.96% | 0.12% | -4.1% | Q1 2015 | |
| $846M | 0.89% | 2.90% | +2.2% | Q1 2018 | |
| $752M | 0.79% | 0.37% | +8.1% | Q1 2015 | |
| $699M | 0.73% | 0.23% | -12.0% | Q1 2015 | |
| $688M | 0.72% | 0.11% | -10.0% | Q1 2015 | |
| $666M | 0.70% | 0.38% | +26.7% | Q1 2015 | |
| $637M | 0.67% | 0.31% | +22.0% | Q1 2015 | |
| $632M | 0.66% | 0.24% | -20.9% | Q1 2015 | |
| $628M | 0.66% | 0.23% | +38.0% | Q1 2015 | |
| $553M | 0.58% | 0.15% | +6.4% | Q1 2015 | |
| $516M | 0.54% | 0.04% | -2.1% | Q1 2015 | |
| $477M | 0.50% | 0.16% | -0.1% | Q1 2015 | |
| $464M | 0.49% | 0.05% | +18.1% | Q1 2015 | |
| $461M | 0.48% | 0.34% | +0.4% | Q1 2015 | |
| $446M | 0.47% | 0.11% | -15.0% | Q1 2015 | |
| $439M | 0.46% | 0.63% | +181.5% | Q1 2015 | |
| $437M | 0.46% | 0.12% | +21.7% | Q4 2020 | |
| $431M | 0.45% | 0.25% | -23.2% | Q1 2015 | |
| $430M | 0.45% | 0.17% | +14.3% | Q1 2015 | |
| $423M | 0.44% | 0.24% | -2.6% | Q1 2015 | |
| $417M | 0.44% | 0.34% | +25.2% | Q1 2015 | |
| $415M | 0.44% | 0.58% | +9.6% | Q1 2015 | |
| PBPMBSPuramed Bioscience Inc. | $413M | 0.43% | 4.17% | +18.4% | Q1 2025 |
| $404M | 0.42% | 0.55% | -5.7% | Q1 2015 | |
| $396M | 0.42% | 0.65% | -4.6% | Q1 2015 | |
| $394M | 0.41% | 0.00% | +2.7% | Q1 2015 | |
| $377M | 0.39% | 0.51% | +5.5% | Q1 2015 | |
| $342M | 0.36% | 1.71% | +0.3% | Q1 2015 | |
| $340M | 0.36% | 0.27% | +27.6% | Q1 2015 | |
| $338M | 0.35% | 0.24% | +31.8% | Q1 2015 | |
| $338M | 0.35% | 1.20% | +28.8% | Q1 2015 | |
| $336M | 0.35% | 0.22% | -4.4% | Q1 2015 | |
| $334M | 0.35% | 0.82% | +1.0% | Q1 2015 | |
| $330M | 0.35% | 0.55% | -8.4% | Q1 2015 | |
| $329M | 0.35% | 0.16% | -17.3% | Q1 2015 | |
| $328M | 0.34% | 0.30% | -32.6% | Q1 2015 | |
| $327M | 0.34% | 0.28% | -9.2% | Q1 2015 | |
| $319M | 0.33% | 0.58% | +4.9% | Q1 2015 | |
| $315M | 0.33% | 0.06% | -23.0% | Q1 2015 | |
| Q4 2025Reported Feb 11, 20261,423 positions | |||||
| $4.06B | 4.10% | 0.09% | +6.5% | Q1 2015 | |
| $3.6B | 3.65% | 0.10% | +14.0% | Q1 2015 | |
| $3.2B | 3.23% | 0.08% | +5.8% | Q1 2015 | |
| $2.42B | 2.45% | Not reported | Not reported | Q1 2025 | |
| $2.18B | 2.20% | 0.09% | +8.0% | Q1 2015 | |
| $2.07B | 2.09% | 0.05% | -4.5% | Q4 2015 | |
| $1.29B | 1.31% | Not reported | -2.7% | Q4 2015 | |
| $1.26B | 1.27% | Not reported | +11.1% | Q1 2015 | |
| $1.25B | 1.26% | 0.25% | +10.3% | Q1 2015 | |
| $1.22B | 1.23% | 0.07% | +10.3% | Q1 2016 | |
| $1.04B | 1.05% | 0.12% | +18.8% | Q1 2015 | |
| $874M | 0.88% | 0.12% | +42.7% | Q1 2015 | |
| $852M | 0.86% | 2.83% | +8.2% | Q1 2018 | |
| $789M | 0.80% | 0.26% | -12.2% | Q1 2015 | |
| $640M | 0.65% | 0.30% | +54.0% | Q1 2015 | |
| $638M | 0.65% | 0.04% | -4.7% | Q1 2015 | |
| $610M | 0.62% | 0.33% | +5.9% | Q1 2015 | |
| $530M | 0.54% | 0.24% | +16.7% | Q1 2015 | |
| $511M | 0.52% | 0.13% | +33.5% | Q1 2015 | |
| $506M | 0.51% | 0.30% | +116.4% | Q1 2015 | |
| $495M | 0.50% | 0.32% | -30.2% | Q1 2015 | |
| $488M | 0.49% | 0.34% | Not reported | Q1 2015 | |
| $475M | 0.48% | 0.07% | -7.2% | Q1 2015 | |
| $459M | 0.46% | 0.05% | +19.5% | Q1 2015 | |
| $452M | 0.46% | 0.68% | +44.6% | Q1 2015 | |
| $447M | 0.45% | 0.25% | +33.0% | Q1 2015 | |
| $439M | 0.44% | 0.14% | +95.5% | Q1 2015 | |
| $436M | 0.44% | 0.10% | +65.6% | Q4 2020 | |
| $426M | 0.43% | 0.44% | +18.6% | Q1 2015 | |
| $418M | 0.42% | 0.05% | -29.3% | Q1 2015 | |
| $418M | 0.42% | 0.16% | +22.7% | Q1 2015 | |
| $406M | 0.41% | 0.14% | +12.8% | Q1 2015 | |
| $376M | 0.38% | 0.23% | -12.1% | Q1 2015 | |
| $361M | 0.37% | 0.21% | +36.6% | Q1 2015 | |
| $353M | 0.36% | 0.30% | +2.9% | Q1 2015 | |
| PBPMBSPuramed Bioscience Inc. | $350M | 0.35% | 3.52% | +31.1% | Q1 2025 |
| $345M | 0.35% | 0.00% | +0.8% | Q1 2015 | |
| $342M | 0.35% | 0.17% | -40.9% | Q1 2015 | |
| $339M | 0.34% | 0.48% | -15.9% | Q1 2015 | |
| $335M | 0.34% | 1.16% | -17.8% | Q1 2015 | |
| $332M | 0.34% | 0.74% | +69.0% | Q1 2015 | |
| $323M | 0.33% | 0.44% | -8.7% | Q1 2015 | |
| $323M | 0.33% | 0.19% | -0.8% | Q1 2015 | |
| $316M | 0.32% | 0.81% | +47.5% | Q1 2015 | |
| $305M | 0.31% | 0.14% | -9.1% | Q1 2015 | |
| $300M | 0.30% | 0.66% | +55.0% | Q1 2015 | |
| $300M | 0.30% | 0.19% | +2.1% | Q2 2016 | |
| $296M | 0.30% | 0.27% | +5.7% | Q1 2015 | |
| $296M | 0.30% | 0.19% | +42.8% | Q2 2015 | |
| $295M | 0.30% | 0.29% | +194.8% | Q1 2015 | |
| Q3 2025Reported Nov 4, 20251,431 positions | |||||
| $5.03B | 5.62% | Not reported | Not reported | Q1 2025 | |
| $3.81B | 4.25% | 0.08% | -1.4% | Q1 2015 | |
| $3.39B | 3.78% | 0.09% | +6.9% | Q1 2015 | |
| $2.83B | 3.16% | 0.08% | -4.5% | Q1 2015 | |
| $1.92B | 2.14% | 0.08% | +7.7% | Q1 2015 | |
| $1.68B | 1.88% | 0.06% | -3.8% | Q4 2015 | |
| $1.26B | 1.40% | Not reported | +5.8% | Q1 2015 | |
| $1.05B | 1.17% | 0.07% | +1.0% | Q1 2016 | |
| $1.03B | 1.15% | Not reported | +5.1% | Q4 2015 | |
| $1.01B | 1.13% | 0.23% | +2.9% | Q1 2015 | |
| $913M | 1.02% | 2.62% | +11.7% | Q1 2018 | |
| $858M | 0.96% | 0.10% | +37.3% | Q1 2015 | |
| $798M | 0.89% | 0.30% | -0.5% | Q1 2015 | |
| $662M | 0.74% | 0.04% | +2.8% | Q1 2015 | |
| $641M | 0.72% | 0.46% | -7.3% | Q1 2015 | |
| $610M | 0.68% | 0.09% | +31.9% | Q1 2015 | |
| $560M | 0.63% | 0.31% | +2.1% | Q1 2015 | |
| $546M | 0.61% | 0.07% | +12.5% | Q1 2015 | |
| $498M | 0.56% | 0.08% | +2.2% | Q1 2015 | |
| $490M | 0.55% | 0.10% | +8.3% | Q1 2015 | |
| $486M | 0.54% | 0.21% | -0.1% | Q1 2015 | |
| $461M | 0.51% | 0.28% | -23.7% | Q1 2015 | |
| $431M | 0.48% | 0.46% | +4.3% | Q4 2020 | |
| $426M | 0.48% | 0.22% | +50.0% | Q1 2015 | |
| $411M | 0.46% | 0.37% | +0.6% | Q1 2015 | |
| $403M | 0.45% | 0.23% | +19.3% | Q1 2018 | |
| $392M | 0.44% | 0.26% | -19.1% | Q1 2015 | |
| $383M | 0.43% | 0.30% | +1.5% | Q1 2015 | |
| $382M | 0.43% | 0.19% | +4.6% | Q1 2015 | |
| $373M | 0.42% | 0.09% | +4.8% | Q1 2015 | |
| $369M | 0.41% | 0.48% | +5.4% | Q1 2015 | |
| $354M | 0.40% | 0.79% | +66.3% | Q1 2015 | |
| $351M | 0.39% | 0.19% | -25.7% | Q1 2015 | |
| $347M | 0.39% | 1.36% | -6.0% | Q1 2015 | |
| $343M | 0.38% | 0.66% | +12.6% | Q1 2015 | |
| $333M | 0.37% | 0.57% | -5.9% | Q1 2015 | |
| $330M | 0.37% | 0.56% | +6.9% | Q1 2015 | |
| $325M | 0.36% | 0.19% | +4.7% | Q1 2015 | |
| $322M | 0.36% | 0.13% | +23.3% | Q1 2015 | |
| $320M | 0.36% | 0.14% | +20.4% | Q1 2015 | |
| $315M | 0.35% | 0.00% | +22.5% | Q1 2015 | |
| $305M | 0.34% | Not reported | -8.1% | Q1 2015 | |
| $302M | 0.34% | 0.47% | -8.5% | Q1 2015 | |
| $288M | 0.32% | 0.54% | +14.5% | Q1 2015 | |
| $286M | 0.32% | 0.11% | +1.7% | Q1 2015 | |
| $282M | 0.32% | 0.42% | +9.5% | Q1 2015 | |
| $281M | 0.31% | 0.15% | -28.0% | Q1 2015 | |
| $273M | 0.31% | 0.19% | -3.7% | Q2 2016 | |
| $273M | 0.30% | 0.04% | -7.4% | Q1 2015 | |
| $271M | 0.30% | 0.13% | +55.2% | Q1 2015 | |
Premium opens every quarter this fund has filed